In the current retrospective study, we compared the MGMT-methylation pattern of isocitrate dehydrogenase (IDH)-wildtype glioblastomas from patients, who survived more than 3 years (long-term survivors) with those who survived less than 1 year (short-term survivors). The gene discussed is IDH2; the disease is glioblastoma.